These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22226255)

  • 1. Bringing the artificial pancreas home: telemedicine aspects.
    Lanzola G; Capozzi D; Serina N; Magni L; Bellazzi R
    J Diabetes Sci Technol; 2011 Nov; 5(6):1381-6. PubMed ID: 22226255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatic data processing to achieve a safe telemedical artificial pancreas.
    Hernando ME; García-Sáez G; Martínez-Sarriegui I; Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Capel I; Pons B; Gómez EJ
    J Diabetes Sci Technol; 2009 Sep; 3(5):1039-46. PubMed ID: 20144417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Device Interoperability for Improved Diabetes Management.
    Silk AD
    J Diabetes Sci Technol; 2015 Jul; 10(1):175-7. PubMed ID: 26178738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bio-inspired Artificial Pancreas for Type 1 Diabetes Control in the Home: System Architecture and Preliminary Results.
    Herrero P; El-Sharkawy M; Daniels J; Jugnee N; Uduku CN; Reddy M; Oliver N; Georgiou P
    J Diabetes Sci Technol; 2019 Nov; 13(6):1017-1025. PubMed ID: 31608656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly.
    Oron T; Farfel A; Muller I; Miller S; Atlas E; Nimri R; Phillip M
    Diabetes Technol Ther; 2014 Nov; 16(11):699-705. PubMed ID: 25211216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting Expectations for Successful Artificial Pancreas/Hybrid Closed Loop/Automated Insulin Delivery Adoption.
    Lewis D
    J Diabetes Sci Technol; 2018 Mar; 12(2):533-534. PubMed ID: 28918653
    [No Abstract]   [Full Text] [Related]  

  • 9. Designing an artificial pancreas architecture: the AP@home experience.
    Lanzola G; Toffanin C; Di Palma F; Del Favero S; Magni L; Bellazzi R
    Med Biol Eng Comput; 2015 Dec; 53(12):1271-83. PubMed ID: 25430423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study.
    Benhamou PY; Huneker E; Franc S; Doron M; Charpentier G;
    Acta Diabetol; 2018 Jun; 55(6):549-556. PubMed ID: 29520615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New and Emerging Technologies in Type 1 Diabetes.
    Sherwood JS; Russell SJ; Putman MS
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):667-678. PubMed ID: 33153673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Pancreas Project at Cambridge 2013.
    Hovorka R
    Diabet Med; 2015 Aug; 32(8):987-92. PubMed ID: 25819473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Controlled Trial of Mobile Closed-Loop Control.
    Kovatchev B; Anderson SM; Raghinaru D; Kudva YC; Laffel LM; Levy C; Pinsker JE; Wadwa RP; Buckingham B; Doyle FJ; Brown SA; Church MM; Dadlani V; Dassau E; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Lum J; Beck RW;
    Diabetes Care; 2020 Mar; 43(3):607-615. PubMed ID: 31937608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.
    Lal RA; Ekhlaspour L; Hood K; Buckingham B
    Endocr Rev; 2019 Dec; 40(6):1521-1546. PubMed ID: 31276160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technological innovation in diabetes: is it suitable for everyone and at what price?].
    Sauvanet JP
    Soins; 2012 Apr; (764 Suppl):S24-8. PubMed ID: 22649858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLOSED-LOOP INSULIN DELIVERY.
    Dinsmoor RS
    Diabetes Self Manag; 2017 Mar; 34(2):48-50. PubMed ID: 29757534
    [No Abstract]   [Full Text] [Related]  

  • 20. The critical path from pump to pancreas: the impact of FDA regulation on the development of a closed-loop diabetes management system.
    Sanchez RM
    Food Drug Law J; 2013; 68(1):53-76, i. PubMed ID: 24640637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.